The bill, passed by 306 to 81 votes on Monday, would prohibit the US government from contracting with, or providing grants to, companies that do business with a "biotechnology company of concern".

Let's dive into a conversation with Ayla Ellison, Fierce Biotech Editor-in-Chief and Michelle ... We hope you can all join us on September 30th and October 1st in Boston. We hope to see you ...

Ginkgo Bioworks is pivoting: Once a synthetic biology darling, the flailing company has now turned to AI-driven protein ...

SALEM, MA, - Rob… An online-only webinar (by Invitation only) for US Corporate execs (CFOs ... a year long… Boston biotech increases target for pending IPO ...

This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. Good morning. It’s another ...

The US funds 90% of the pharma spend in the world.” Accessing 21st century science, utilising (advanced) tech To work with such technologies as the cloud, AI, and machine learning, UK biotech ...

US BIOTECH company Thermo Fisher Scientific, Inc. said it is expanding its Philippine workforce to staff a new Quezon City facility. “Our new global business services center will enhance and expand ...

In the first legislative moves of “China week”, the US House passed a bill on Monday that would restrict the federal government from contracting with Chinese biotech firms involved in the US ...

In years gone by, governments underwrote the development of new technologies before opening the doors to the private sector ...

COPENHAGEN, Denmark and MUNICH, Sept. 17, 2024 /PRNewswire/ -- MinervaX ApS, a privately held Danish biotechnology company developing a novel, prophylactic vaccine against Group B Streptococcus ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...